IPO intraday trading strategy idea
Neximmune is a clinical-stage biotechnology company developing a novel approach to immunotherapy designed to employ the body’s own T cells to generate a specific, potent and durable immune response that mimics natural biology.
The share price is rising and gonna continue this trend today.
The demand for shares of the company...
